K2M Group Hldngs Cmn (KTWO) 17.28 $KTWO
K2M Expands MESA(R) Platform with FDA Clearance for Growing Spine Application
GlobeNewswire - Wed Sep 21, 6:00AM CDT
K2M Group Holdings, Inc. (NASDAQ:KTWO) (the "Company" or "K2M"
, a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine and minimally invasive spine technologies and techniques, today announced at the Scoliosis Research Society (SRS) 51 Annual Meeting & Course in Prague, Czech Republic that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for screw and connector components toward a growing spine application for its MESA Spinal System. This clearance enables these screw and connector components to be used as a part of a growing rod construct designed to accommodate growth in patients under 10 years of age.
KTWO: 17.28 (-0.24)
K2M Group Holdings, Inc. to Present at Two Investor Conferences in September
GlobeNewswire - Thu Sep 01, 9:00AM CDT
K2M Group Holdings, Inc. (NASDAQ:KTWO) (the "Company" or "K2M" , a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine and minimally invasive spine technologies and techniques, today announced management will present at the following investor conferences in September:
WFC: 45.74 (+0.02), KTWO: 17.28 (-0.24)
K2M Group Holdings, Inc. Announces Pricing of Private Offering of $50 Million Aggregate Principal Amount of 4.125% Convertible Senior Notes due 2036
GlobeNewswire - Mon Aug 08, 8:00AM CDT
K2M Group Holdings, Inc. (Nasdaq:KTWO) ("K2M" or the "Company" today announced the pricing of a private offering of $50 million aggregate principal amount of 4.125% Convertible Senior Notes due 2036 (the "Notes" , to be sold only to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act" . The offering is expected to close on August 11, 2016, subject to customary closing conditions.
KTWO: 17.28 (-0.24)
K2M Group Holdings, Inc. Reports Second Quarter 2016 Financial Results; Reaffirms Fiscal Year 2016 Outlook
GlobeNewswire - Wed Aug 03, 3:16PM CDT
K2M Group Holdings, Inc. (Nasdaq:KTWO) (the "Company" or "K2M" , a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine and minimally invasive spine technologies and techniques, today reported financial results for the second quarter ended June 30, 2016.
KTWO: 17.28 (-0.24)
K2M Group Holdings, Inc. to Present at the JMP Securities Life Sciences Conference 2016
GlobeNewswire - Mon Jun 13, 7:30AM CDT
K2M Group Holdings, Inc. (NASDAQ:KTWO) (the "Company" or "K2M" , a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine and minimally invasive spine technologies and techniques, today announced that the Company's Chief Financial Officer, Greg Cole, will participate in the JMP Securities Life Sciences Conference 2016 at the St. Regis New York. Mr. Cole will host a presentation with investors on Tuesday, June 21, 2016 at 9:30 a.m. Eastern Time.
KTWO: 17.28 (-0.24)
K2M Enhances 3D-Printed Spine Portfolio Following FDA Clearance of Two CASCADIA(TM) Interbody Systems Featuring Lamellar 3D Titanium Technology(TM)
GlobeNewswire - Wed Jun 01, 7:00AM CDT
K2M Group Holdings, Inc. (NASDAQ:KTWO) (the "Company" or "K2M" , a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine and minimally invasive spine technologies and techniques, today announced it has received 510(k) clearances from the U.S. Food and Drug Administration (FDA) to market the CASCADIA Cervical and the CASCADIA AN Lordotic Oblique Interbody Systems featuring Lamellar 3D Titanium Technology, the Company's innovative technology that uses 3D printing with the goal of allowing for bony integration throughout an implant.
KTWO: 17.28 (-0.24)
Global Spine Implants Market 2016 - Forecasts To 2022 - The US Leads the Way - Research and Markets
PR Newswire Europe - Fri May 20, 12:11PM CDT
Research and Markets has announced the addition of the "Spine Implants Global Market - Forecast To 2022" [http://www.researchandmarkets.com/research/zbr323/spine_implants] report to their offering.
JNJ: 118.81 (-0.65), ZBH: 128.33 (-0.54), MDT: 87.71 (-0.11), GMED: 22.58 (-0.22), KTWO: 17.28 (-0.24)
K2M Group Holdings, Inc. to Present at Upcoming Investor Conferences
GlobeNewswire - Thu May 19, 3:00PM CDT
K2M Group Holdings, Inc. (NASDAQ:KTWO) (the "Company" or "K2M" , a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine and minimally invasive spine technologies and techniques, today announced that management will present at the following investor conferences in May and June:
KTWO: 17.28 (-0.24)
Research Supporting Favorable Findings on K2M's RAVINE(R) Lateral Access System to Be Presented at SpineWeek 2016
GlobeNewswire - Mon May 16, 7:30AM CDT
K2M Group Holdings, Inc. (NASDAQ:KTWO) (the "Company" or "K2M" , a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine and minimally invasive spine technologies and techniques, today announced that research on K2M's RAVINE Lateral Access System will be presented at the SpineWeek 2016 Annual Meeting, occurring May 16-20 in Singapore.
KTWO: 17.28 (-0.24)
K2M Group Holdings, Inc. Reports First Quarter 2016 Financial Results, Led by U.S. Revenue Growth of 20% year-over-year, and Updates 2016 Outlook
GlobeNewswire - Mon May 02, 3:01PM CDT
K2M Group Holdings, Inc. (Nasdaq:KTWO) (the "Company" or "K2M" , a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine and minimally invasive technologies and techniques, today reported financial results for the first quarter ended March 31, 2016.
KTWO: 17.28 (-0.24)
K2M Hosts Leading Spine Surgeons at the 2016 Meeting of Minds(TM)
GlobeNewswire - Thu Apr 28, 10:55AM CDT
K2M Group Holdings, Inc. (Nasdaq:KTWO) (the "Company" or "K2M" , a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine and minimally invasive spine technologies and techniques, hosted more than 120 of the world's leading spine surgeons for its annual Meeting of Minds in Chicago, Illinois on April 22-23, 2016. Meeting of Minds offers spine surgeons a premiere, world-class curriculum in the latest approaches and techniques for the operative treatment of spinal disorders.
KTWO: 17.28 (-0.24)
K2M Group Holdings, Inc. to Release First Quarter 2016 Financial Results on May 2nd
GlobeNewswire - Thu Apr 21, 3:30PM CDT
K2M Group Holdings, Inc. (NASDAQ:KTWO) (the "Company" or "K2M" , a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine and minimally invasive spine technologies and techniques, today announced plans to release first quarter 2016 financial results after market close on May 2nd.
KTWO: 17.28 (-0.24)
K2M Receives CE Mark for Its Next-Generation RHINE(TM) Cervical Disc System
Thomson Reuters ONE - Thu Jan 21, 5:19PM CST
K2M's Cervical Artificial Disc Replacement Features Proprietary Molding Technology to Minimize Wear Between Polymer Core and Metal Endplates
KTWO: 17.28 (-0.24)
K2M Group Holdings, Inc. Reports Preliminary Fourth Quarter and Full Year 2015 Financial Results With 17% Annual Growth
GlobeNewswire - Mon Jan 11, 7:11AM CST
K2M Group Holdings, Inc. (Nasdaq:KTWO) (the "Company" or "K2M" , a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine and minimally invasive technologies and techniques, today reported preliminary financial results for the fourth quarter and full year ended December 31, 2015.
KTWO: 17.28 (-0.24)
K2M Expands Minimally Invasive Spine Portfolio With Addition of Its CASCADIA(TM) Lateral Interbody System Featuring Lamellar Titanium Technology(TM)
GlobeNewswire - Fri Jan 08, 7:30AM CST
K2M Group Holdings, Inc.(Nasdaq:KTWO), a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine technologies, techniques and minimally invasive procedures, today announced it has recently received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the CASCADIA Lateral Interbody System featuring Lamellar Titanium Technology, the Company's innovative and proprietary technology that uses 3D printing with the goal of allowing for bony integration throughout an implant. In addition to U.S. regulatory clearance, K2M also received a CE Mark for the system, which allows the Company to expand the global availability of the product.
KTWO: 17.28 (-0.24)
BUYINS.NET: KTWO SqueezeTrigger Price is $19.63. There is $14,797,741 That Short Sellers Still Need To Cover.
M2 - Tue Jan 05, 9:27AM CST
JBUYINS.NET / www.squeezetrigger.com is monitoring K2 DIGITAL INC (NASDAQ:KTWO) in real time and just received an alert that KTWO is crossing above its primary SqueezeTrigger Price, the price that a short squeeze can start in any stock. There are 752300 shares that have been shorted at the volume weighted average SqueezeTrigger Price of $19.63. To access SqueezeTrigger Prices ahead of potential short squeezes beginning, visit http://www.squeezetrigger.com .
KTWO: 17.28 (-0.24)
Direction of Market Influences - Analyst Research on Eclipse Resources, Nobilis Health, Merit Medical Systems and K2M Group Holdings
ACCESSWIRE - Thu Dec 24, 6:36AM CST
NEW YORK, NY / ACCESSWIRE / December 24, 2015 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Eclipse Resources Corp. (NYSE: ECR), Nobilis Health Corp. (NYSE: HLTH), Merit Medical Systems Inc. (NASDAQ: MMSI) and K2M Group Holdings Inc. (NASDAQ: KTWO). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
HLTH: 3.41 (-0.09), ECR: 3.24 (-0.17), KTWO: 17.28 (-0.24), MMSI: 23.96 (-0.32)
BUYINS.NET: KTWO SqueezeTrigger Price is $19.62. There is $14,883,960 That Short Sellers Still Need To Cover.
M2 - Mon Dec 21, 10:41AM CST
BUYINS.NET / www.squeezetrigger.com is monitoring K2 DIGITAL INC (NASDAQ:KTWO) in real time and just received an alert that KTWO is crossing above its primary SqueezeTrigger Price, the price that a short squeeze can start in any stock. There are 754000 shares that have been shorted at the volume weighted average SqueezeTrigger Price of $19.62. To access SqueezeTrigger Prices ahead of potential short squeezes beginning, visit http://www.squeezetrigger.com .
KTWO: 17.28 (-0.24)
K2M Expands MIS Portfolio With Addition of Its EVEREST(R) Minimally Invasive XT Spinal System
GlobeNewswire - Wed Dec 16, 7:00AM CST
K2M Group Holdings, Inc. (Nasdaq:KTWO) (the "Company" or "K2M" , a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine technologies, techniques, and minimally invasive procedures, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the EVEREST Minimally Invasive (MI) XT Spinal System, the Company's latest addition to the family of EVEREST products. In addition to U.S. regulatory clearance, K2M also received a CE Mark for the system, which allows the Company to expand the global availability of the product.
KTWO: 17.28 (-0.24)
K2M Expands MESA(R) Platform with FDA Clearance for Growing Spine Application
GlobeNewswire - Wed Sep 21, 6:00AM CDT
K2M Group Holdings, Inc. (NASDAQ:KTWO) (the "Company" or "K2M"
, a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine and minimally invasive spine technologies and techniques, today announced at the Scoliosis Research Society (SRS) 51 Annual Meeting & Course in Prague, Czech Republic that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for screw and connector components toward a growing spine application for its MESA Spinal System. This clearance enables these screw and connector components to be used as a part of a growing rod construct designed to accommodate growth in patients under 10 years of age. KTWO: 17.28 (-0.24)
K2M Group Holdings, Inc. to Present at Two Investor Conferences in September
GlobeNewswire - Thu Sep 01, 9:00AM CDT
K2M Group Holdings, Inc. (NASDAQ:KTWO) (the "Company" or "K2M"
, a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine and minimally invasive spine technologies and techniques, today announced management will present at the following investor conferences in September: WFC: 45.74 (+0.02), KTWO: 17.28 (-0.24)
K2M Group Holdings, Inc. Announces Pricing of Private Offering of $50 Million Aggregate Principal Amount of 4.125% Convertible Senior Notes due 2036
GlobeNewswire - Mon Aug 08, 8:00AM CDT
K2M Group Holdings, Inc. (Nasdaq:KTWO) ("K2M" or the "Company"
today announced the pricing of a private offering of $50 million aggregate principal amount of 4.125% Convertible Senior Notes due 2036 (the "Notes" , to be sold only to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act" . The offering is expected to close on August 11, 2016, subject to customary closing conditions. KTWO: 17.28 (-0.24)
K2M Group Holdings, Inc. Reports Second Quarter 2016 Financial Results; Reaffirms Fiscal Year 2016 Outlook
GlobeNewswire - Wed Aug 03, 3:16PM CDT
K2M Group Holdings, Inc. (Nasdaq:KTWO) (the "Company" or "K2M"
, a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine and minimally invasive spine technologies and techniques, today reported financial results for the second quarter ended June 30, 2016. KTWO: 17.28 (-0.24)
K2M Group Holdings, Inc. to Present at the JMP Securities Life Sciences Conference 2016
GlobeNewswire - Mon Jun 13, 7:30AM CDT
K2M Group Holdings, Inc. (NASDAQ:KTWO) (the "Company" or "K2M"
, a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine and minimally invasive spine technologies and techniques, today announced that the Company's Chief Financial Officer, Greg Cole, will participate in the JMP Securities Life Sciences Conference 2016 at the St. Regis New York. Mr. Cole will host a presentation with investors on Tuesday, June 21, 2016 at 9:30 a.m. Eastern Time. KTWO: 17.28 (-0.24)
K2M Enhances 3D-Printed Spine Portfolio Following FDA Clearance of Two CASCADIA(TM) Interbody Systems Featuring Lamellar 3D Titanium Technology(TM)
GlobeNewswire - Wed Jun 01, 7:00AM CDT
K2M Group Holdings, Inc. (NASDAQ:KTWO) (the "Company" or "K2M"
, a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine and minimally invasive spine technologies and techniques, today announced it has received 510(k) clearances from the U.S. Food and Drug Administration (FDA) to market the CASCADIA Cervical and the CASCADIA AN Lordotic Oblique Interbody Systems featuring Lamellar 3D Titanium Technology, the Company's innovative technology that uses 3D printing with the goal of allowing for bony integration throughout an implant. KTWO: 17.28 (-0.24)
Global Spine Implants Market 2016 - Forecasts To 2022 - The US Leads the Way - Research and Markets
PR Newswire Europe - Fri May 20, 12:11PM CDT
Research and Markets has announced the addition of the "Spine Implants Global Market - Forecast To 2022" [http://www.researchandmarkets.com/research/zbr323/spine_implants] report to their offering.
JNJ: 118.81 (-0.65), ZBH: 128.33 (-0.54), MDT: 87.71 (-0.11), GMED: 22.58 (-0.22), KTWO: 17.28 (-0.24)
K2M Group Holdings, Inc. to Present at Upcoming Investor Conferences
GlobeNewswire - Thu May 19, 3:00PM CDT
K2M Group Holdings, Inc. (NASDAQ:KTWO) (the "Company" or "K2M"
, a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine and minimally invasive spine technologies and techniques, today announced that management will present at the following investor conferences in May and June: KTWO: 17.28 (-0.24)
Research Supporting Favorable Findings on K2M's RAVINE(R) Lateral Access System to Be Presented at SpineWeek 2016
GlobeNewswire - Mon May 16, 7:30AM CDT
K2M Group Holdings, Inc. (NASDAQ:KTWO) (the "Company" or "K2M"
, a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine and minimally invasive spine technologies and techniques, today announced that research on K2M's RAVINE Lateral Access System will be presented at the SpineWeek 2016 Annual Meeting, occurring May 16-20 in Singapore. KTWO: 17.28 (-0.24)
K2M Group Holdings, Inc. Reports First Quarter 2016 Financial Results, Led by U.S. Revenue Growth of 20% year-over-year, and Updates 2016 Outlook
GlobeNewswire - Mon May 02, 3:01PM CDT
K2M Group Holdings, Inc. (Nasdaq:KTWO) (the "Company" or "K2M"
, a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine and minimally invasive technologies and techniques, today reported financial results for the first quarter ended March 31, 2016. KTWO: 17.28 (-0.24)
K2M Hosts Leading Spine Surgeons at the 2016 Meeting of Minds(TM)
GlobeNewswire - Thu Apr 28, 10:55AM CDT
K2M Group Holdings, Inc. (Nasdaq:KTWO) (the "Company" or "K2M"
, a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine and minimally invasive spine technologies and techniques, hosted more than 120 of the world's leading spine surgeons for its annual Meeting of Minds in Chicago, Illinois on April 22-23, 2016. Meeting of Minds offers spine surgeons a premiere, world-class curriculum in the latest approaches and techniques for the operative treatment of spinal disorders. KTWO: 17.28 (-0.24)
K2M Group Holdings, Inc. to Release First Quarter 2016 Financial Results on May 2nd
GlobeNewswire - Thu Apr 21, 3:30PM CDT
K2M Group Holdings, Inc. (NASDAQ:KTWO) (the "Company" or "K2M"
, a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine and minimally invasive spine technologies and techniques, today announced plans to release first quarter 2016 financial results after market close on May 2nd. KTWO: 17.28 (-0.24)
K2M Receives CE Mark for Its Next-Generation RHINE(TM) Cervical Disc System
Thomson Reuters ONE - Thu Jan 21, 5:19PM CST
K2M's Cervical Artificial Disc Replacement Features Proprietary Molding Technology to Minimize Wear Between Polymer Core and Metal Endplates
KTWO: 17.28 (-0.24)
K2M Group Holdings, Inc. Reports Preliminary Fourth Quarter and Full Year 2015 Financial Results With 17% Annual Growth
GlobeNewswire - Mon Jan 11, 7:11AM CST
K2M Group Holdings, Inc. (Nasdaq:KTWO) (the "Company" or "K2M"
, a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine and minimally invasive technologies and techniques, today reported preliminary financial results for the fourth quarter and full year ended December 31, 2015. KTWO: 17.28 (-0.24)
K2M Expands Minimally Invasive Spine Portfolio With Addition of Its CASCADIA(TM) Lateral Interbody System Featuring Lamellar Titanium Technology(TM)
GlobeNewswire - Fri Jan 08, 7:30AM CST
K2M Group Holdings, Inc.(Nasdaq:KTWO), a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine technologies, techniques and minimally invasive procedures, today announced it has recently received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the CASCADIA Lateral Interbody System featuring Lamellar Titanium Technology, the Company's innovative and proprietary technology that uses 3D printing with the goal of allowing for bony integration throughout an implant. In addition to U.S. regulatory clearance, K2M also received a CE Mark for the system, which allows the Company to expand the global availability of the product.
KTWO: 17.28 (-0.24)
BUYINS.NET: KTWO SqueezeTrigger Price is $19.63. There is $14,797,741 That Short Sellers Still Need To Cover.
M2 - Tue Jan 05, 9:27AM CST
JBUYINS.NET / www.squeezetrigger.com is monitoring K2 DIGITAL INC (NASDAQ:KTWO) in real time and just received an alert that KTWO is crossing above its primary SqueezeTrigger Price, the price that a short squeeze can start in any stock. There are 752300 shares that have been shorted at the volume weighted average SqueezeTrigger Price of $19.63. To access SqueezeTrigger Prices ahead of potential short squeezes beginning, visit http://www.squeezetrigger.com .
KTWO: 17.28 (-0.24)
Direction of Market Influences - Analyst Research on Eclipse Resources, Nobilis Health, Merit Medical Systems and K2M Group Holdings
ACCESSWIRE - Thu Dec 24, 6:36AM CST
NEW YORK, NY / ACCESSWIRE / December 24, 2015 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Eclipse Resources Corp. (NYSE: ECR), Nobilis Health Corp. (NYSE: HLTH), Merit Medical Systems Inc. (NASDAQ: MMSI) and K2M Group Holdings Inc. (NASDAQ: KTWO). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
HLTH: 3.41 (-0.09), ECR: 3.24 (-0.17), KTWO: 17.28 (-0.24), MMSI: 23.96 (-0.32)
BUYINS.NET: KTWO SqueezeTrigger Price is $19.62. There is $14,883,960 That Short Sellers Still Need To Cover.
M2 - Mon Dec 21, 10:41AM CST
BUYINS.NET / www.squeezetrigger.com is monitoring K2 DIGITAL INC (NASDAQ:KTWO) in real time and just received an alert that KTWO is crossing above its primary SqueezeTrigger Price, the price that a short squeeze can start in any stock. There are 754000 shares that have been shorted at the volume weighted average SqueezeTrigger Price of $19.62. To access SqueezeTrigger Prices ahead of potential short squeezes beginning, visit http://www.squeezetrigger.com .
KTWO: 17.28 (-0.24)
K2M Expands MIS Portfolio With Addition of Its EVEREST(R) Minimally Invasive XT Spinal System
GlobeNewswire - Wed Dec 16, 7:00AM CST
K2M Group Holdings, Inc. (Nasdaq:KTWO) (the "Company" or "K2M"
, a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine technologies, techniques, and minimally invasive procedures, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the EVEREST Minimally Invasive (MI) XT Spinal System, the Company's latest addition to the family of EVEREST products. In addition to U.S. regulatory clearance, K2M also received a CE Mark for the system, which allows the Company to expand the global availability of the product. KTWO: 17.28 (-0.24)
